HNR1 Stock Analysis: Hannover Rück SE | XETRA
Insurance - Reinsurance | XETRA, Germany | Market Cap: 32.489m EUR | 12M Return: 13.8% | DE0008402215 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 33.8M
EPS Trend: 96.4%
Qual. Beats: 0
Rev. Trend: -0.5%
Qual. Beats: 0
Warnings
Tailwinds
No distinct edge detected
Seasonality 11.7 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
Hannover Rück SE is a global reinsurer headquartered in Hanover, Germany, operating as a subsidiary of Talanx AG. Founded in 1966 and renamed from Hannover Rückversicherung AG in March 2013, the company serves clients across Europe, the Americas, Asia, Australia, and Africa through two core segments: Property & Casualty Reinsurance and Life & Health Reinsurance.
The Property & Casualty segment covers a broad range of specialty lines, including aviation and space, marine and energy, credit and surety, cyber, agricultural and bloodstock, natural catastrophe, and structured and parametric solutions. The Life & Health segment provides reinsurance covering critical illness, disability, mortality, longevity, and long-term care, as well as group life, retirement, credit life, and Takaful products.
In addition to traditional risk transfer, the company offers financial solutions such as new-business financing, embedded value monetization, and reserve and solvency relief. Reinsurers like Hannover Rück help primary insurers manage capital, volatility, and regulatory requirements under frameworks such as the European Unions Solvency II directive, acting as a key capacity provider to the global insurance industry.
- Catastrophe losses and pricing pressure shape P&C underwriting margins
- Higher interest rates lift investment income on reinsurance float
- Life & Health reinsurance margins improve on longevity trends
| Net Income: 9.08b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.09 > 0.02 and ΔFCF/TA 1.09 > 1.0 |
| NWC/Revenue: 3.65% < 20% (prev 4.90k%; Δ -4.90k% < -1%) |
| CFO/TA 0.09 > 3% & CFO 6.46b > Net Income 9.08b |
| Net Debt (3.16b) to EBITDA (3.72b): 0.85 < 3 |
| Current Ratio: error (cannot be calculated; needs correct Total Current Assets and Liabilities) |
| Outstanding Shares: last quarter (120.6m) vs 12m ago -0.03% < -2% |
| Gross Margin: 94.03% > 18% (prev 88.97%; Δ 5.05% > 0.5%) |
| Asset Turnover: 118.3% > 50% (prev 1.66%; Δ 116.7% > 0%) |
| Interest Coverage Ratio: 29.76 > 6 (EBIT TTM 3.72b / Interest Expense TTM 124.9m) |
| A: 0.04 (Total Current Assets 3.10b - Total Current Liabilities 0.0) / Total Assets 74.4b |
| B: 0.17 (Retained Earnings 12.6b / Total Assets 74.4b) |
| C: 0.05 (EBIT TTM 3.72b / Avg Total Assets 71.9b) |
| D: 0.22 (Book Value of Equity 13.3b / Total Liabilities 60.1b) |
| Altman-Z'' = 1.41 = BB |
| DSRI: 0.10 (Receivables 2.04b/1.78b, Revenue 85.0b/1.15b) |
| GMI: 0.95 (GM 88.97% / 94.03%) |
| AQI: 5.43 (AQ_t 0.96 / AQ_t-1 0.18) |
| SGI: 74.02 (Revenue 85.0b / 1.15b) |
| TATA: 0.04 (NI 9.08b - CFO 6.46b) / TA 74.4b) |
| Beneish M = 51.17 (Cap -4..+1) = D |
As of October 17, 2026, the stock is trading at EUR 274.40 with a total of 131,702 shares traded. Over the past week, the price has changed by +4.26%, over one month by +7.27%, over three months by +8.89% and over the past year by +13.84%.
Current recommended Stop Loss: 267.90 (which is 2.4% or 1.4 ATR below the current price).
Hannover Rück SE has no consensus analysts rating.
P/E Trailing = 11.8314
P/E Forward = 10.4603
P/S = 1.4334
P/B = 2.3036
P/EG = 4.7566
Revenue TTM = 85.0b EUR
EBIT TTM = 3.72b EUR
EBITDA TTM = 3.72b EUR
Long Term Debt = 4.05b EUR (from longTermDebt, last fiscal year)
Short Term Debt = 181.7m EUR (from shortTermDebt, last fiscal year)
Debt = 4.22b EUR (from shortLongTermDebtTotal, last quarter) + Leases 92.1m
Net Debt = 3.16b EUR (calculated: Debt 4.22b - CCE 1.06b)
Enterprise Value = 35.6b EUR (32.5b + Debt 4.22b - CCE 1.06b)
Interest Coverage Ratio = 29.76 (Ebit TTM 3.72b / Interest Expense TTM 124.9m)
EV/FCF = 5.52x (Enterprise Value 35.6b / FCF TTM 6.46b)
FCF Yield = 18.12% (FCF TTM 6.46b / Enterprise Value 35.6b)
FCF Margin = 7.59% (FCF TTM 6.46b / Revenue TTM 85.0b)
Net Margin = 10.67% (Net Income TTM 9.08b / Revenue TTM 85.0b)
Gross Margin = 94.03% ((Revenue TTM 85.0b - Cost of Revenue TTM 5.08b) / Revenue TTM)
Gross Margin QoQ = 29.02% (prev none%)
Tobins Q-Ratio = 0.48 (Enterprise Value 35.6b / Total Assets 74.4b)
Interest Expense / Debt = 2.96% (Interest Expense 124.9m / Debt 4.22b)
Taxrate = 18.99% (682.2m / 3.59b)
NOPAT = 3.01b (EBIT 3.72b * (1 - 18.99%))
Current Ratio = unknown (Total Current Assets 3.10b / Total Current Liabilities 0.0)
Debt / Equity = 0.32 (Debt 4.22b / totalStockholderEquity, last quarter 13.3b)
Debt / EBITDA = 0.85 (Net Debt 3.16b / EBITDA 3.72b)
Debt / FCF = 0.49 (Net Debt 3.16b / FCF TTM 6.46b)
Total Stockholder Equity = 13.0b (last 4 quarters mean from totalStockholderEquity)
RoA = 12.63% (Net Income 9.08b / Total Assets 74.4b)
RoE = 69.73% (Net Income TTM 9.08b / Total Stockholder Equity 13.0b)
RoCE = 21.78% (EBIT 3.72b / Capital Employed (Equity 13.0b + L.T.Debt 4.05b))
RoIC = 3.87% (NOPAT 3.01b / Invested Capital 77.8b)
WACC = 4.87% (E(32.5b)/V(36.7b) * Re(5.19%) + D(4.22b)/V(36.7b) * Rd(2.96%) * (1-Tc(0.19)))
Discount Rate = 5.19% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -28.97 | Cagr: 0.02%
[DCF] Terminal Value 77.97% ; FCFF base≈5.98b ; Y1≈6.86b ; Y5≈10.1b
[DCF] Fair Price = 1.23k (EV 152b - Net Debt 3.16b = Equity 149b / Shares 120.6m; r=8.35% [WACC [floored]]; 5y FCF grow 15.0% → 2.50% )
EPS Correlation: 96.44 | EPS CAGR: 17.35% | SUE: 0.67 | # QB: 0
Revenue Correlation: -0.52 | Revenue CAGR: -0.90% | SUE: 0.02 | # QB: 0
EPS current Quarter (2026-09-30): EPS=5.40 | Chg30d=+0.00% | Revisions=+40% | Analysts=4
EPS current Year (2026-12-31): EPS=23.24 | Chg30d=+0.11% | Revisions=+50% | GrowthEPS=+6.1% | GrowthRev=+0.2%
EPS next Year (2027-12-31): EPS=23.62 | Chg30d=-0.03% | Revisions=+10% | GrowthEPS=+1.7% | GrowthRev=+3.6%
[Analyst] Revisions Ratio: +42% (up=12, down=4)